Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Garlic has beneficial effects in model of volume overload heart failure

July 7, 1997

Roche's T-type calcium channel blocker receives European approval

July 3, 1997

Novel antifibrillatory agent: DP-16

July 3, 1997

Pharmacological profile of BMS-186716 characterized

July 2, 1997

Antioxidant diester reported by Senju

July 2, 1997

Roche describes endothelin antagonists

July 2, 1997

ET antagonists claimed by Bristol-Myers Squibb

July 2, 1997

JTV-506: a potent and selective coronary vasodilator from Japan Tobacco

July 1, 1997

YM-435 shows promise in acute hypertensive episodes

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...